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1. Introduction 
1.1 Definition 
Amblyopia in Greek is dullness of vision. It is defined as poor unilateral or bilateral visual 
acuity due to poor perception in the presence of normal appearing globe.1 It is caused by 
poor visual perception during the critical postnatal period required for maturation of the 
visual pathways and cortex. Clear and corresponding image is required for visual system 
development in animals including primates.  
1.2 Epidemiology 
The prevalence of amblyopia in the general population is probably between 2 and 2.5%. The 
wider range of 1-4% reflects differences in the degree of amblyopia, the studied population 
and the location. These figures represent the average of the prevalence in the different 
studies. The frequency of disorder has a socioeconomic impact. These patients have a 
greater risk for legal blindness if the fellow eye develops a blinding condition or sustain 
trauma. Indeed, patients with amblyopia as monocular patients are at a greater risk for 
trauma in the fellow eye although their visual field may be full.  
1.3 Development of the visual system 
The postnatal visual system development differs in different animals. In humans, the visual 
acuity improves usually until the age of 5 and this reflects the maturation of both the retina 
and the visual pathways.2 The most critical period for amblyopia is the first 2 to 3 years of 
life.1 The sensitivity of the visual system to abnormal perception is decreasing gradually 
afterwards. One should distinguish between the period when amblyopia may develop, 
which is until 9 years of age (although in most patients, it appears by the age of 5) and the 
period in which it is treatable, probably until the age of 17.3  
1.4 Classification 
Amblyopia is a result of three mechanisms: deprivation (obscuration of the image on its way 
to the retina (i.e., ptosis and media opacities), strabismus and refractive (anisometropic  
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or isoamteropic) all causing blurred or non-corresponding images on the fovea.1 The 
pathophysiology common to all of these is abnormal binocular interaction and/ or vision 
deprivation. Strabismic amblyopia occurs in the non-fixating eye and is always unilateral. It 
occurs in tropia and is more common in esotropia than in exotropia and indeed esotropia is 
neonatal while exotropia may be neonatal or acquired later in life.  It is caused by signaling 
inhibition of the deviating eye to avoid confusion because of different foveal images between 
the eyes. Strabismic amblyopia is applied only to cases where the amblyopia is a result of 
strabismus and not vice versa. In refractive amblyopia, signaling inhibition of the blurred 
image occurs and in deprivation, there is usually no image. Anisometropia of +2.00, -3.00 and 
astigmatism of 1.5D or more are associated with amblyopia. The presence of astigmatism 
causes amblyopia in the astigmatic meridian called meridional amblyopia. Isoametropia of 
+4.00, -8.00 and astigmatism of 2D or more are associated with bilateral amblyopia. Lesser 
amount of hypermetropia than myopia is associated with amblyopia because the inability to 
focus images on the fovea at any distance. While strabismic amblyopia and most of the 
anisometropic amblyopia are unilateral, isoametropic and some of the deprivative amblyopia 
are bilateral. Deprivative amblyopia is usually the most profound and most resistant to 
treatment of all three forms of amblyopia. If it is present in the first 3 months, irreversible 
nystagmus develops. The unilateral cases are usually the worst. 
2. Clinical manifestations 
The visual acuity is poorer in the amblyopic eye than in the fellow eye or than in normal 
eyes and cannot be corrected to full with spectacles or contact lenses. A poorer visual acuity 
is considered if the visual acuity is less in two Snellen lines or more. Differences in one line 
may just be fluctuation and within the normal deviation and this is true not only for 
amblyopia but for all other instances as well. The subject uses the fellow better eye for 
fixation. The patient sees single signs on the Snellen chart better than several signs in a row 
(crowding phenomenon or abnormal contour interaction). This is caused by larger receptive 
fields (larger group of photoreceptors working as a single unit) and lateral inhibition by 
adjacent fields on the fixating field. Under dim light, the visual acuity decreases in both eyes 
but the visual acuity of amblyopic eye becomes similar to the normal eye. Thus the decrease 
in visual acuity is slower in the amblyopic eye than in a normal eye. The use of neutral 
density filters decreases the visual acuity in the amblyopic eye in much lesser extent 
compared with eyes with other diseases. In addition, amblyopic eyes have decreased 
contrast sensitivity, perception of brightness and have longer reaction time.   
Other parameters are normal and similar to normal eyes including light perception (visual 
threshold) and visual field. An afferent pupillary defect is not supposed to occur but is a 
variable finding.  
3. Treatment 
Bilateral amblyopia is treated by eliminating the cause of blurred image (removal of the 
deprivation cause, strabismus surgery or refractive error correction). Unilateral amblyopia is 
treated similarly along with periodical patching or other penalization of the fellow sound 
eye. Penalization of the sound eye is usually performed by instilling once drop of atropine 
sulfate 1% one a day at bedtime. This causes cycloplegia and blurred image in the sound eye 
and forces the visual system of the amblyopic eye to act. Treatment should be initiated 
immediately when the condition is diagnosed. The elimination of the deprivative obstacle 
should be performed as early as possible (usually 2-3 weeks after birth). In strabismic 
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amblyopia, anti-amblyopic treatment is initiated when the condition is diagnosed long 
before the surgery for strabismus. The reasons for this are improving the possibility to gain 
binocular vision if visual acuity is improved, easiness to determine the fixation patters, and 
the strabismus serves as a reminder to the parents on the importance of treatment. Surgery 
is performed only after achieving alternating fixation and equal visual acuity. 
The length of patching or other penalization depends on the severity of the amblyopia. It is 
increased in direct proportion with the degree of the amblyopia. The follow-up frequency is 
also increased as the length of patching increases. Amblyopia is more easily reversible if it 
occurs later (ages 6-9) than earlier in life. Improvement of visual acuity should be both in 
single and multiple signs on Snellen chart and should be permanent. However, regression 
may occur and requires re-treatment. 
Occlusion may be for full-time (all the day) for several days with one day off, or part time 
(several hours per day). Full-time occlusion is preserved for severe amblyopia with no 
binocular vision such as deprivative amblyopia. Full-time occlusion should not exceed one 
week per one year of age. Part-time treatment is preferred according to the Pediatric Eye 
Disease Investigator Group (PEDIG) studies because it has a similar outcome as full-time 
occlusion with less risk for development of amblyopia in the normal fellow eye, especially in 
the presence of binocular vision and mild amblyopia. Six hours per day of occlusion are 
sufficient for severe amblyopia of less than 20/100 and 2-3 hours per day for moderate one 
(better than 20/100). Contact lenses may be employed in anisometropia of more than 3.00D 
to prevent aniseikonia. However, this is more demanding treatment. Bilateral amblyopia in 
isoammteropia is usually not treated with occlusion and improves slowly spontaneously 
once refractive correction has been applied. In all cases, it is essential to rule out the 
development of amblyopia in the sound eye during treatment.  
Obtaining compliance is difficult especially at the beginning of the treatment. The 
compliance becomes better as visual acuity of the amblyopic eye improves. Children try to 
remove or pick through the occluder. Therefore, it is better to use eye drops as penalization 
or a skin sticker rather than a sticker to the eyeglass. A full cooperation is required from the 
parents. They should be insisting on meticulous treatment for the full period. It is best to 
occlude when the child is at home under supervision of the parents and to occlude when the 
child is performing near tasks such as reading or doing homework. A close follow-up is 
required to ascertain improvement in visual acuity of the amblyopic eye and prevention of 
developing amblyopia in the fellow eye. In general, the follow-up intervals are one week per 
each year of life (e.g., a 2-year-old child is followed every 2 weeks). The follow-up includes 
visual acuity in each eye with full cycloplegic correction after refraction. If the visual acuity 
decreases, the reason for it should be disclosed. If the correction is not sufficient, it should be 
adjusted accordingly. If it is sufficient, an adjustment of the anti-amblyopic treatment 
should be performed. The length of occlusion is gradually decreased if the visual acuity 
improves to the desired level and no regression is observed in follow-up visits. Occlusion is 
gradually tapered according to the patient’s response. Gradual decrease in occlusion time 
has been demonstrated to be associated with less recurrence rate than abrupt determination. 
If regression is noted, the treatment is re-initiated and continued over the vulnerable period 
(up to the age of 17). Follow-up until the age of 17 is necessary even if the optimal results 
have been achieved. Recurrence occurs in up to 75% of the patients usually within the first 
13 months.4 If treatment has not been successful after several (usually 6) months, it may be 
abandoned and visual function will not improve thereafter. 
In animal models, L-dopa and bicuculline have been demonstrated to reverse amblyopia. 
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However, they have not been used in humans because the first one showed only a 
temporary effect and the second can cause seizures. 
4. Prevention 
Prevention of amblyopia is of outmost importance. Screening of red reflex at birth should be 
done to all neonates. Screening programs at preschool and school children are also important. 
5. Background 
To date, no changes in gross anatomy of the eye were found in the human amblyopic eye. 
When optical coherence tomography (OCT) was employed to evaluate the overall macular 
thickness, volume and the retinal nerve fiber layer (RNFL) thickness, it was found that all 
were similar in one study between strabismic amblyopic and the fellow eyes in 14 patients.5 
Another study did report thicker RNFL in amblyopic eyes than in normal fellow eyes.6 
When the differences in RNFL thickness were compared between amblyopic eyes and 
normal eyes of other subjects, they were found to be statistically insignificant.7 In this study, 
the foveal thickness in the amblyopic eyes was similar to normal control eyes (p=0.551), but 
the authors did not compare it with the normal fellow eye. It would be expected that any 
differences in the anatomy in vivo between amblyopic and normal eyes would be 
microscopic. One should also consider the reproducibility of the OCT and the normal 
variations between normal eyes at different ages. Therefore, to show differences, a 
comparison should be made first with the fellow normal eye in unilateral amblyopia. 
We compared the foveal thickness of amblyopic eyes with the fellow normal eye by OCT. 
Furthermore, we compared the foveal thickness of amblyopic eyes that underwent 
successful occlusion therapy with amblyopic eyes refractory to treatment. Such a study has 
not been previously reported according to Medline® search. The rationale for the current 
study was that even if the gross anatomy is normal, subtle structural variations such as 
foveal hypoplasia might exist.  
6. Methods 
In a prospective study, we compared the foveal thickness of amblyopic eyes with the fellow 
normal eyes in unilateral strabismic and anisometropic amblyopia by OCT (spectral 
OCT/SLO, OTI, Ophthalmic Technologies, Toronto, Canada). The inclusion criteria included 
best-corrected visual acuity (BCVA) of 20/80 or less in the involved eye, BCVA of 20/25 or 
better of the fellow eye, normal eye exam of each eye and no explanation for the low visual 
acuity except for amblyopia, presence of one of the causes for amblyopia (anisometropia of 
more than –3.00D or more than +1.00D, or strabismus), no other ocular, neurologic or systemic 
disorders, and children between 4 and 10 years of age who can undergo OCT and be treated 
for amblyopia and that followed the treatment orders. All other patients were excluded from 
the study. Ocular and general medical history were obtained and the patients underwent a 
complete ophthalmic examination of each eye including visual acuity by Snellen charts, pupil 
reactions, slit lamp examination, dilated funduscopic examination with a slit lamp 
biomicroscopy and indirect ophthalmoscopy. 
All eyes were analyzed by OCT. Measurement was performed at the thinnest point of the 
macular center, representing the fovea. Several topographic 3D, linear and radial scans were 
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obtained. The acceptance criteria of OCT included a central reflex, signal strength of at least 4 and 
standard deviation of the foveal thickness of less than 10% of the mean for each individual.  
Amblyopic patients with refractive errors were treated by refractive full cycloplegic 
correction. Amblyopic patients with strabismus underwent strabismus surgery. All patients 
underwent occlusion (patching) therapy of the sound eye at least 6 for months and were 
followed according to previous recommendations.3,8-10 Successful treatment was defined as 
an improvement in visual acuity in the amblyopic eye in at least 2 Snellen lines. The follow-
up time ranged between 12 and 54 months. 
Statistical analysis was performed with SPSS version 11.5 program (SPSS Inc., Chicago, IL, 
USA). Paired sample T-test was used for samples larger than 15 and Wilcoxon signed rank 
test was employed for smaller samples. Two-tailed p<0.05 was considered as statistically 
significant. Approval by the IRB/Ethics Committee was obtained and the patients’ parents 
received a full explanation about the exam.  
7. Patients 
Nineteen children aged 4-10 with unilateral amblyopia were included. Ten patients had 
anisometropic (refractive) and 9 had strabismic amblyopia. Eight patients had successful 
occlusion therapy, while the other 11 had unsuccessful treatment.  
8. Results 
The foveal thickness in amblyopic eyes was 201±42 µm (average±SD) and in the normal 
fellow eyes 174±27 µm. The fovea was statistically thicker in the amblyopic eyes of whatever 
cause than in the normal fellow eye (p=0.011, paired sample T-test). The foveal thickness in 
eyes with anisometropic amblyopia (n=10) was 194±45 µm and in the fellow eyes of the 
same patients 167±23 µm (p=0.059, Wilcoxon signed rank test). The foveal thickness in eyes 
with strabismic amblyopia (n=9) was 210±39 µm and in the fellow eyes of the same patients 
181± 30 µm (p=0.070, Wilcoxon signed rank test).  
Eight (42%) of the 19 patients experienced improvement in BCVA after occlusion therapy. 
Six of the 8 had anisometropic and 2 had strabismic amblyopia. From the group of 11 (58%) 
patients that did not show improvement in BCVA, 4 had anisometropic and 7 had 
strabismic amblyopia (p=1.000). The foveal thickness in the patients who showed no 
improvement in BCVA after treatment was 216±41 µm and in their fellow eyes 176±31 µm 
(p=0.016, Wilcoxon signed rank test) (Table 1). In those who showed improvement, the 
foveal thickness in the amblyopic eyes was 181±36 µm and in their fellow eyes 171±21 µm 
(p=0.297, Wilcoxon signed rank test). Examples of the topographic 3-dimensional OCT maps 
of an amblyopic and normal fellow eye are seen in figures 1 and 2.  
 
Parameter Amblyopic eye Fellow eye P-value 
Total (n=19) 201±42 174±27 0.011 
Refractive (n=10) 194±45 167±23 0.059 
Strabismic (n=9) 210±39 181±30 0.070 
VA improvement (n=8) 216±41 176±31 0.016 
No VA improvement (n=11) 181±36 171±21 0.297 
Mean±SD in µm 
Table 1. The foveal thickness in µm as measured by optical coherence tomography in 
amblyopic versus the normal fellow eye. 
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Fig. 1. A topographic 3-dimensional OCT image of the right amblyopic eye of a 10-year-old 
boy that was refractory to treatment measured a foveal thickness of 195 µm. 
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Fig. 2. A topographic 3-dimensional OCT image of the left normal eye of the same patient as 
in figure 1 measured a foveal thickness of 167 µm. The fovea was thinner in this normal eye 
than the amblyopic eye. 
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9. Discussion  
Amblyopic eyes are classically considered as having a normal structure.1 The only changes 
that have been found were smaller parvocellular cells in layers II, III and V in the ipsilateral 
lateral geniculate body, layers I, IV and VI of the contralateral lateral geniculate body and 
reduction in the number of cells in the primary (striate) visual cortex V1 receiving input 
from the affected eye.11,12 Reduction was noted in the number of cells receiving binocular 
input. An increase in the number of cortical cells responding to a contour orientation also 
occurs. Positron emission tomography demonstrated a reduced cortical activity under visual 
stimulation of the amblyopic eye.13 
We found that in the amblyopic eyes the fovea was thicker than in the normal fellow eyes. 
This was common both for anisometropic and strabismic eyes. Our finding is supported by 
a recent study in 3,529 children aged 6-12 years that found thicker fovea in amblyopic eyes 
than in the normal fellow eyes by 5µm.14 These and our results differ from a recent 
evaluation of the foveal thickness that did not show statistically significant differences 
(p=0.551) of the foveae in patients with unilateral anisometropic and strabismic amblyopia 
compared with normal subjects.7 Nonetheless, the authors did not compare the amblyopic 
eye with the normal fellow eyes and therefore, did not have an internal control. The 
differences between our study and the previous one probably relate to variability of foveal 
thickness in different individuals and indeed such differences were found between different 
individuals in our study and therefore the standard deviation between different individual 
was quite high. 
Careful review of the OCT images indicated that the foveal thickening was due to either 
thicker outer retinal layers or immature retinal tissue. The structural feature of the foveae in 
amblyopic eyes is hypoplasia similar to albinotic and nanophthalmic eyes.15-18 The fovea is 
thicker and flatter in these eyes. Since there are no histologic preparations of the retina in 
amblyopic eyes, it is impossible to determine the exact composition of the foveal area. 
However, in oculocutaneous albinism the retinal tissue was intact and the Bruch's layer was 
thickened in one specimen.19 
We found that amblyopic eyes refractory to occlusion therapy had thicker fovea than those 
of the normal fellow eyes, while the differences in thickness between amblyopic eyes that 
responded to treatment and the fellow eyes were insignificant. This finding could have been 
different if patients and their parents would not be cooperative. No previous study 
addressed this issue and therefore we cannot compare our data with previous ones. 
In our study, patients with anisometropic amblyopia had not statistical significant success of 
the occlusion therapy compared with patients with strabismic amblyopia. The differences in 
foveal thickness in the amblyopic and the sound fellow eyes in each group were not 
statistically significant although they were marginal in the amblyopic eyes of the 
anisometropic group. The higher number of anisometropic patients that underwent successful 
occlusion therapy might explain this tendency. A larger population will be required to confirm 
if the foveal thickness differs in these two groups and if the type of the amblyopia is the cause 
for different foveal thickness rather than treatment success. The higher success of occlusion 
therapy in anisometropic amblyopia than in strabismic amblyopia might be related to the 
thinner foveae in anisometropic patients. Thicker foveae were found in strabismic than in 
anisometropic amblyopia in another study as well (p=0.046).7 
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In our sample, the foveae of the amblyopic eyes were thicker than in the fellow normal eyes 
except for one in which the thickness was the same and another 3 with thicker normal fovea. 
Two of these patients experienced an improvement in BCVA after occlusion therapy. If in all 
future patients, the fovea of the amblyopic eye will be thicker than in the fellow normal eye, 
the foveal thickness may serve as a prognostic factor for improvement after proper therapy. 
To validate this, more patients should be recruited and a scale should be established for the 
measures that may predict improvement or non-improvement. It is possible that there will 
be patients in whom the fovea in the amblyopic eye would be thinner than in the normal 
fellow eye and would not experience an improvement in BCVA after treatment. In such 
event, it may not be possible to predict the success of a treatment based on the foveal 
thickness at least in those patients. 
In patients with bilateral amblyopia, measurements of each fovea and a comparison with 
normal foveae will be needed. In such cases, the differences might be subtle as after 
comparing unilateral amblyopic eyes with normal controls and prediction of successful 
treatment may be difficult. According to our findings, it might be worthwhile to create a 
database for foveal thickness in the normal population according to age, since the foveal 
thickness may change with age.20 In addition, a correlation between BCVA and foveal 
thickness might be established as well. 
OCT measurements in children are demanding because of inattention, especially in children 
under age 4. In addition, amblyopic eyes tend to fixate less and if nystagmus is present, clear 
images may not be possible to obtain, unless the eye is mechanically fixated. We should also 
consider the accuracy and reproducibility of the OCT. When assessing thin layers as in the 
fovea, if the accuracy and reproducibility are not perfect, subtle differences may not be 
measured accurately, even if the image resolution is of 2µm. For macular thickness, OCT 
was found accurate and reproducible21 and it is expected that with better technologies 
including high-resolution Fourier-domain OCT, this problem will be solved.  
It will be interesting to verify our results in amblyopic adults and to find what is the foveal 
thickness in children that had regression after treatment. The last and the most intriguing 
issue is whether treatment influences the foveal thickness. Since the fovea, as well as other 
structures such as the lateral geniculate body and visual cortex, continue to develop after 
birth (the “critical” period), it is tempting to hypothesize that in successful treatment, the 
foveal thickness might also change. 
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